Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer

11 Jan 2021

Abstract excerpt

BACKGROUND: Cisplatin-based chemotherapy is recommended as the primary treatment for advanced bladder cancer (BC) with unresectable or metastatic disease. However, the benefits are limited due to the acquisition of drug resistance. The mechanisms of resistance remain unclear. Although there are some reports that some molecules are associated with cisplatin resistance in advanced BC, those reports have not been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer, Hypoxia, and Metabolism
Share to Cancer, Lipids, and Metabolism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33430801
DOI: 10.1186/s12885-020-07717-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancerPMID 33430801Read ↗

Epigenetic silencing of miR-200b is associated with cisplatin resistance in bladder cancerSemantic proximity Read ↗

Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell linesSemantic proximity Read ↗

DHCR7 promotes tumorigenesis via activating PI3K/AKT/mTOR signalling pathway in bladder cancerSemantic proximity Read ↗

MiR-486-5p enhances cisplatin sensitivity of human muscle-invasive bladder cancer cells by induction of apoptosis and down-regulation of metastatic genesSemantic proximity Read ↗

The role of miRNA-424 in various cancers: Focusing on drug resistance and sensitivitySemantic proximity Read ↗

miR‐30e‐5p suppresses cell proliferation and migration in bladder cancer through regulating metadherinSemantic proximity Read ↗

The role of microRNA in cisplatin resistance or sensitivitySemantic proximity Read ↗

The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancerSemantic proximity Read ↗

Effects and mechanisms of AMIGO2 in proliferation, migration and drug resistance of bladder cancerSemantic proximity Read ↗

LncRNA DDX11-AS1 promotes breast cancer progression via targeting the miR-30c-5p/MTDH axisSemantic proximity Read ↗

CircLIFR synergizes with MSH2 to attenuate chemoresistance via MutSα/ATM-p73 axis in bladder cancerSemantic proximity Read ↗

LncSNHG14 promotes the development and progression of bladder cancer by targeting miRNA-150-5p.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.